Indeed, alteration of the histone acetyltransferase (HAT)/HDAC balance towards elevated histone deacetylation and enhanced transcription of tumor suppressor genes is well documented in bladder cancer [17]. This evidence concerns the gene HDAC9 and urinary bladder cancer.